|North American Clinical Trials Network (NACTN)
The mission of the North American Clinical Trials Network (NACTN) for the Treatment of Spinal Cord Injury is to bring promising therapies out of the laboratory and into clinical trials, in a manner that provides evidence of effectiveness and safety.
NACTN aims to examine the natural history of spinal cord injury and advance measures for assessing treatment success. Network collaborations will provide the foundation for a global system that will speed therapeutic development and ensure that powerful new therapies will be made available to those in need.
The NACTN Registry is a repository of standardized, de-identified data collected from patients presenting with a new traumatic spinal cord injury (SCI) at a network of clinical centers. Data collected includes imaging information from CT or MRI scans, neurological and general medical outcome and rehabilitation evaluation.